PNV 1.15% $2.58 polynovo limited

The Clinicians Speak, page-845

  1. 2,922 Posts.
    lightbulb Created with Sketch. 183
    Nice to be reminded

    Conclusion:
    Economically, although the net profit per square centimeter of dermal template may favor IDRT, the ancillary benefits associated with BTM in terms of reduced hospital stay, shorter surgery times, fewer follow-up visits, and lower revisionary surgery rates contribute substantially to overall cost-effectiveness. Biodegradable Temporizing Matrix use reflects more efficient resource use and potential cost savings, aligning with broader trends in healthcare emphasizing value-based and patient-centered care.

    https://pubmed.ncbi.nlm.nih.gov/38556669/

 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.